Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma

Background: Despite advances in therapeutics, outcomes for hepatocellular carcinoma (HCC) remain poor and there is an urgent need for efficacious systemic therapy. Unfortunately, drugs that are successful in preclinical studies often fail in the clinical setting, and we hypothesize that this is due...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weining, Iyer, N. Gopalakrishna, Tay, Hsien Ts’ung, Wu, Yonghui, Lim, Tony K. H., Zheng, Lin, Song, In Chin, Kwoh, Chee Keong, Huynh, Hung, Tan, Patrick O. B., Chow, Pierce K. H.
Otros Autores: School of Computer Engineering
Formato: Journal Article
Lenguaje:English
Publicado: 2015
Materias:
Orthotopic
Xenograft
HepG2 cell line
Hepatocellular carcinoma
Ectopic
Acceso en línea:https://hdl.handle.net/10356/80966
http://hdl.handle.net/10220/38996

Internet

https://hdl.handle.net/10356/80966
http://hdl.handle.net/10220/38996

Ejemplares similares